#ADA2020 Bempedoic acid lowers LDL regardless of glycemic status
Researchers found that bempedoic acid significantly reduced LDL compared with placebo in patients with diabetes, prediabetes or normoglycemia and hypercholesterolemia. Bempedoic acid (Nexletol, Esperion Therapeutics) is a first-in-class ATP-citrate lyase…